PlainMeds provides educational information only. This is not medical advice. Always consult your doctor or pharmacist.

Drug side effects

lithium Side Effects

The reactions most often reported to the FDA for lithium (also sold as Lithobid, Eskalith), with demographics, serious outcomes, and reporting trends.

Data updated 2026-05-15

24,367
FAERS reports

Data from the FDA Adverse Event Reporting System (FAERS), 2004 to 2025. A FAERS report records a temporal association, not proof of cause. See our methodology for how figures are compiled and de-duplicated.

The most commonly reported side effects of lithium come from 24,367 reports to the FDA, broken down here by frequency, patient demographics, and serious outcomes.

This page analyzes 24,367 reports to the FDA Adverse Event Reporting System (FAERS) for lithium (Lithobid): the reactions reported most often, who reported them, serious outcomes such as hospitalization, and year-over-year trends. A FAERS report does not prove the drug caused the effect, and report volume tracks how widely a drug is used, not how likely an effect is for any one person. Educational information, not medical advice.

Total Reports

24,367

Reports Mentioning Death

2,021

8.3% of reports — not proof the medicine caused the death

Hospitalizations

9,664

39.7% of reports

Top Indication

Product Used For Unknown Indication

Most Reported Adverse Reactions

TOXICITY TO VARIOUS AGENTS
2,179
DRUG INTERACTION
1,526
TREMOR
1,462
NAUSEA
1,344
WEIGHT INCREASED
1,153
FATIGUE
1,065
VOMITING
1,016
DEPRESSION
986
ANXIETY
961
SOMNOLENCE
914
INSOMNIA
899
SUICIDAL IDEATION
891
DIZZINESS
819
CONFUSIONAL STATE
800
CONDITION AGGRAVATED
795
DIARRHOEA
768
MANIA
756
COMPLETED SUICIDE
714

Who Reports Side Effects

Gender Distribution

Female 12,862 (58%)
Male 9,271 (42%)
Unknown 127

Age Distribution

0-17 1,239 (7%)
18-44 6,806 (39%)
45-64 6,672 (39%)
65-74 1,877 (11%)
75+ 716 (4%)

Reporting Trend by Year

2004 2025

Reactions in Death Reports

Top reactions reported in 2,021 reports where death was an outcome. These are voluntarily reported and do not establish causation.

Reaction Reports
COMPLETED SUICIDE 714
TOXICITY TO VARIOUS AGENTS 428
DEATH 325
OVERDOSE 141
CARDIO-RESPIRATORY ARREST 140
CARDIAC ARREST 134
SEIZURE 87
DIARRHOEA 85
PSYCHOTIC DISORDER 85
FATIGUE 83
PLATELET COUNT DECREASED 82
LEUKOPENIA 79
NAUSEA 78
NEUTROPENIA 77
PNEUMONIA 77
COVID-19 75
EXTRAPYRAMIDAL DISORDER 72
SCHIZOPHRENIA 72
SUSPECTED SUICIDE 72

Reactions in Hospitalization Reports

Top reactions in 9,664 reports where hospitalization was an outcome.

Reaction Reports
TOXICITY TO VARIOUS AGENTS 1,479
DRUG INTERACTION 849
NAUSEA 664
TREMOR 654
VOMITING 629
CONFUSIONAL STATE 521
PSYCHOTIC DISORDER 480
SUICIDE ATTEMPT 475
OVERDOSE 467
PNEUMONIA 463
NEUROLEPTIC MALIGNANT SYNDROME 457
SUICIDAL IDEATION 453
CONDITION AGGRAVATED 450
WEIGHT INCREASED 437
SCHIZOPHRENIA 433
MANIA 428
DIARRHOEA 419
ACUTE KIDNEY INJURY 413

Compare lithium vs acamprosate →

What the FAERS Data Reveals About lithium Side Effects

The FDA Adverse Event Reporting System (FAERS) contains 24,367 voluntary reports linked to lithium and its brand equivalents (Lithobid, Eskalith), spanning 2004 through 2025. Of those, 2,021 (8.3%) listed death as an outcome and 9,664 (39.7%) involved hospitalization. The most common indication reported alongside adverse events was Product Used For Unknown Indication.

Demographic breakdowns help contextualize who is being exposed to the drug. Of reports with known sex, 58% were female and 42% male; age distribution skews toward 18-44, with 6,806 reports in that bracket. The single most reported reaction is toxicity to various agents with 2,179 submissions, followed by drug interaction and tremor.

How to read these numbers

FAERS is a signal-detection tool, not a scorecard. Reports are voluntary, and a single case may list multiple suspect drugs, so numbers above should not be read as incidence rates or per-patient risk. Widely prescribed drugs naturally accumulate more reports than niche therapies even when individual risk is low. These aggregates are useful for spotting patterns that merit further pharmacovigilance, not for choosing between medications. This page is for educational reference only and is not medical advice, speak with a licensed clinician about any side-effect concerns.